Easterly Investment Partners LLC raised its holdings in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 75.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 206,009 shares of the company's stock after purchasing an additional 88,574 shares during the quarter. Easterly Investment Partners LLC's holdings in Nutrien were worth $10,232,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of the business. Allworth Financial LP lifted its holdings in Nutrien by 117.1% during the 1st quarter. Allworth Financial LP now owns 938 shares of the company's stock worth $50,000 after buying an additional 506 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Nutrien by 4,866.7% during the 1st quarter. GAMMA Investing LLC now owns 1,043 shares of the company's stock worth $52,000 after buying an additional 1,022 shares during the last quarter. Summit Securities Group LLC lifted its holdings in Nutrien by 225.0% during the 4th quarter. Summit Securities Group LLC now owns 1,300 shares of the company's stock worth $58,000 after buying an additional 900 shares during the last quarter. HM Payson & Co. bought a new position in Nutrien during the 1st quarter worth approximately $65,000. Finally, Lee Danner & Bass Inc. bought a new position in Nutrien during the 4th quarter worth approximately $67,000. Institutional investors and hedge funds own 63.10% of the company's stock.
Nutrien Stock Performance
Shares of NYSE NTR traded up $1.68 during midday trading on Friday, hitting $60.00. The company's stock had a trading volume of 2,566,839 shares, compared to its average volume of 2,191,729. The stock has a fifty day moving average price of $59.77 and a 200 day moving average price of $54.42. Nutrien Ltd. has a one year low of $43.70 and a one year high of $65.08. The company has a current ratio of 1.22, a quick ratio of 0.59 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $29.22 billion, a price-to-earnings ratio of 56.08, a P/E/G ratio of 1.11 and a beta of 0.80.
Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.24). Nutrien had a net margin of 2.05% and a return on equity of 6.08%. The firm had revenue of $4.67 billion during the quarter, compared to the consensus estimate of $5.16 billion. During the same period in the previous year, the business earned $0.46 earnings per share. The firm's revenue for the quarter was down 5.4% on a year-over-year basis. On average, research analysts forecast that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.
Nutrien Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, July 18th. Shareholders of record on Monday, June 30th were paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 3.63%. The ex-dividend date of this dividend was Monday, June 30th. Nutrien's dividend payout ratio (DPR) is presently 203.74%.
Analyst Ratings Changes
A number of research firms have weighed in on NTR. Royal Bank Of Canada restated an "outperform" rating on shares of Nutrien in a research report on Monday, July 14th. BNP Paribas upgraded shares of Nutrien to a "strong-buy" rating in a research note on Wednesday, April 9th. Jefferies Financial Group reiterated a "hold" rating and issued a $66.00 target price (up from $63.00) on shares of Nutrien in a research note on Friday, July 11th. Berenberg Bank raised their target price on shares of Nutrien from $54.00 to $59.00 and gave the company a "buy" rating in a research note on Tuesday, April 15th. Finally, Scotiabank lowered shares of Nutrien from an "outperform" rating to a "sector perform" rating and set a $62.00 price objective for the company. in a research report on Thursday, May 22nd. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Nutrien has a consensus rating of "Hold" and a consensus target price of $62.78.
Read Our Latest Research Report on NTR
Nutrien Company Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
See Also
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
